$Unique_ID{BRK01852}
$Pretitle{}
$Title{Pharmaceutical Research on Breast Cancer}
$Subject{breast cancer breasts chest medication medications medicine medicines
pharmaceuticals pharmaceutical research medical research tumor tumors}
$Volume{}
$Log{}

Copyright (c) 1993  Tribune Media Services, Inc.


A Resource About Pharmaceutical Research on Breast Cancer


------------------------------------------------------------------------------

     America's pharmaceutical research companies are currently developing 37
medicines for the prevention or treatment of breast cancer, according to a new
publication released by the Pharmaceutical Manufacturers Association (PMA).
The 20 page publication, titled "Pharmaceutical Frontiers:  Research on Breast
Cancer" is the second in the PMA's "Pharmaceutical Frontiers" series.
     Of the 37 medicines being developed, involving 19 companies and the
National Cancer Institute, 24 are being developed to inhibit or suppress tumor
growth, 8 are to destroy cancer cells in the breast and 2 are to cause a
reduction in the extent of the tumor.
     The publication also contains statistics about breast cancer and patient
support information provided by the American Cancer Society, The National
Cancer Institute, CancerCare, and the National Alliance of Breast Cancer
Organizations.  You may obtain your copy by writing to:  "Breast
Cancer", PMA, 11000 Fifteenth Street NW, Washington, DC 20005.

----------------

The material contained here is "FOR INFORMATION ONLY" and should not replace
the counsel and advice of your personal physician.  Promptly consulting your
doctor is the best path to a quick and successful resolution of any medical
problem.